The current stars of synthetic biology Synthetic biology has expanded from a field of a few groups focused on engineering small genetic systems to a major part of bioengineering 1 , where researchers undertake international genome projects 2 and launch high-value companies. Most of the foundational work that can be justifiably termed biological engineering has been done in bacteria, especially in Escherichia coli, which can now count, calculate, sense, see, respond to and carry out a plethora of interesting and valuable things. This has been driven by E. coli being well-studied and exceptionally amenable to genetic engineering. However, compared with the possibilities offered by most organisms, E. coli is frankly quite boring.
For eukaryote synthetic biology, the pace is being set by the yeast Saccharomyces cerevisiae, which, like E. coli, is well characterized, grows quickly and is easy to stably transform. As such, it is well-suited for projects that require advanced genetic engineering, such as metabolic biosynthesis or genome redesign 2 . However, S. cerevisiae is not really representative of eukaryotes, especially when engineering DNA: it only has a minimal level of chromatin, lacks RNAi, has no alternative splicing and rarely undergoes any type of cell differentiation. It is effectively a 'eukaryote lite' , and, along with E. coli, is a starter kit for biological engineers. Most eukaryotic cells we study are much more challenging to engineer, with more layers of regulation and with the differentiation and specialism that comes from multicellularity. Yet it is precisely the specialist nature of most eukaryotic cells that makes them attractive for synthetic biologists working towards applications beyond biosynthesis. When also considering that we, and most of what we eat, are eukaryotes, it becomes obvious why we seek to advance synthetic biology in complex organisms for energy, agricultural and medical applications.
Diversity and multicellularity
So what are the main challenges holding back the engineering of eukaryotes, from filamentous fungi through to worms, mosses, flies, trees, fish, bananas, humans, diatoms and slugs? For a start, it is the two things that attract us to them the most: their diversity and their multicellularity. Their fascinating diversity means that research efforts rarely focus on a single model organism or cell line, and they therefore cannot represent whole kingdoms, phyla or classes. We know a little about how to genetically manipulate many different organisms, whereas complex synthetic biology requires deeper knowledge and new tools. Perhaps predictable engineering for eukaryotes could be accelerated if everyone agreed to work on only a handful of model organisms such as mice, fruitflies and thale cress. This would certainly improve fundamental capabilities for these organisms, but it is debatable whether it would be widely beneficial, as it is unlikely to be straightforward to transfer knowledge and tools from model organisms to their more readily applied relatives, such as humans, mosquitos and crops.
Multicellularity is an exciting property to exploit, but it is challenging, especially for mammalian synthetic biology where many different cell types could be engineered. For example, do we know enough about each cell type to be able to engineer a genetic system that will function similarly in all the cells of an organism, or, alternatively, only operate in a specific cell subset? Our understanding of tissue-specific tools, such as transcription factors, is currently limited. To make headway, we typically perform foundational work in quick-to-grow and easy-to-transform cell lines. Yet these cells and their growth conditions are often not very representative of cells in the original organisms, as they are typically derived from tumours. This also means they are more prone to genomic rearrangements, mutations and epigenetic changes, which make robust genome engineering much more challenging. The increased availability of induced pluripotent stem cells will hopefully help solve some of these issues and should provide a new focus point, particularly for expanding human synthetic biology and for applications such as tissue and organoid generation and utilization. The challenges of eukaryotic DNA Part of the reason why cell lines are popular is because it is difficult to introduce DNA constructs into most primary eukaryotic cells. Indeed, it would be fair to say that nothing holds back eukaryote synthetic biology more than the poor transformation rates of most cells and organisms. In addition, their slow growth means that it often takes months to stably integrate a multigene system into the genome of any eukaryote. Yet, stable transformation is essential to avoid the short-term performance and high variability of transient transfections. Viruses are emerging as the workhorses for reliable DNA delivery into eukaryotic cells. Future efforts to engineer modular viruses that efficiently deliver large DNA constructs and can be reprogrammed to target many hosts would greatly benefit synthetic biology. Placing DNA accurately into the genome is also a challenge. CRISPR-based tools and cell lines preengineered to contain 'landing pads' that promote site-specific integration into reliable chromosomal regions are now aiding this. Artificial chromosomes provide a promising alternative that can be used to host multiple synthetic constructs without disrupting the native genome. Although human artificial chromosomes and their equivalents have been around for decades, synthetic biology efforts should now spur the construction of a new generation made not just to be reliable long-term vectors but also designed for inherent portability into other organisms 3 . Community efforts to establish modular 'neochromosomes' for different branches of eukaryota will be of great value and will hopefully accelerate the use of standardized DNA modules and tools.
Modular programming of DNA is well-established in synthetic biology, but the added complexity of chromatin, alternative splicing and post-translation modifications provides different mechanisms for gene regulation and enforcing feedback beyond the basic transcription regulation programmes used in bacteria and yeast. Our current approach to the design of genetic circuits is largely based on the synthesis of bare plasmids, where the DNA is written to encode the functions. But what if, in addition to DNA, we could write chromatin in modules? Genes and pathways could be packaged into chromatin-like structures that could be activated or silenced using just small changes in a few chromatin remodelling factors. This would allow for more constructs to be co-regulated, and efforts in this area could exploit the recent development of synthetic and orthogonal chromatin-remodelling factors 4 .
Opportunities for progress Orthogonality -separating the engineered systems from those of the host cell -could also be pursued by taking advantage of subcellular compartmentalization, a natural feature of eukaryotes. We can take inspiration from mitochondria and chloroplasts, which operate their own genetic programmes, and from organelles like peroxi somes that perform isolated metabolism. Synthetic organelles could be designed to run gene expression programmes, protein-protein interactions or metabolic pathways in ways that intentionally minimize the interactions with the host biology. This would greatly simplify the many considerations currently required when engineering within a cell's highly connected systems.
In bacteria, the challenges of engineering with consideration to the host are being aided by the increased use of transcriptomics and whole-cell modelling approaches, which are improving the characterization of synthetic constructs and enabling prediction of how they dynamically function in a growing host cell. This should also be a viable future strategy for most eukaryotes, given the surge in 'omics' data now available for many organisms, especially for the main mammalian models. Ultimately, the more knowledge we have on the biology of the host and how this is altered by synthetic engineering, the faster progress in the field will be. The ultimate goal of being able to design and build a full custom synthetic genome for a mammalian cell 5 will require significant technological advances, but also much more understanding of eukaryotic biology in general and increased communication between those working to study cells and those trying to (re)build them.
